315 related articles for article (PubMed ID: 18385684)
1. Getting to the stem of chronic myeloid leukaemia.
Savona M; Talpaz M
Nat Rev Cancer; 2008 May; 8(5):341-50. PubMed ID: 18385684
[TBL] [Abstract][Full Text] [Related]
2. Chronic myeloid leukaemia: stem cell derived but progenitor cell driven.
Marley SB; Gordon MY
Clin Sci (Lond); 2005 Jul; 109(1):13-25. PubMed ID: 15966868
[TBL] [Abstract][Full Text] [Related]
3. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
[TBL] [Abstract][Full Text] [Related]
4. BCR-ABL in chronic myelogenous leukemia--how does it work?
Goldman JM; Melo JV
Acta Haematol; 2008; 119(4):212-7. PubMed ID: 18566539
[TBL] [Abstract][Full Text] [Related]
5. Chronic myeloid leukemia stem cells.
Kavalerchik E; Goff D; Jamieson CH
J Clin Oncol; 2008 Jun; 26(17):2911-5. PubMed ID: 18539972
[TBL] [Abstract][Full Text] [Related]
6. Applying the discovery of the Philadelphia chromosome.
Sherbenou DW; Druker BJ
J Clin Invest; 2007 Aug; 117(8):2067-74. PubMed ID: 17671641
[TBL] [Abstract][Full Text] [Related]
7. Imatinib resistance in CML.
Volpe G; Panuzzo C; Ulisciani S; Cilloni D
Cancer Lett; 2009 Feb; 274(1):1-9. PubMed ID: 18653275
[TBL] [Abstract][Full Text] [Related]
8. Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells.
Jiang X; Saw KM; Eaves A; Eaves C
J Natl Cancer Inst; 2007 May; 99(9):680-93. PubMed ID: 17470736
[TBL] [Abstract][Full Text] [Related]
9. [Chronic myeloid leukemia as a model for the development and therapeutic use of tyrosine kinase inhibitors].
López-Karpovitch X
Rev Invest Clin; 2003; 55(2):191-5. PubMed ID: 12827926
[No Abstract] [Full Text] [Related]
10. Novel therapeutic approach to eradicate tyrosine kinase inhibitor resistant chronic myeloid leukemia stem cells.
Naka K; Hoshii T; Hirao A
Cancer Sci; 2010 Jul; 101(7):1577-81. PubMed ID: 20491777
[TBL] [Abstract][Full Text] [Related]
11. CML resistance to tyrosine kinase inhibitors: how is the laboratory to tell?
Goldman J
Lab Hematol; 2004; 10(3):181-4. PubMed ID: 15529444
[No Abstract] [Full Text] [Related]
12. CML: a model for targeted therapy.
Cilloni D; Saglio G
Best Pract Res Clin Haematol; 2009 Sep; 22(3):285-94. PubMed ID: 19959080
[TBL] [Abstract][Full Text] [Related]
13. [Molecular pathogenesis of chronic myeloid leukemia].
Sasaki K; Mitani K
Nihon Rinsho; 2009 Oct; 67(10):1894-9. PubMed ID: 19860186
[TBL] [Abstract][Full Text] [Related]
14. Treatment strategies for CML.
Goldman JM
Best Pract Res Clin Haematol; 2009 Sep; 22(3):303-13. PubMed ID: 19959082
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of chronic myeloid leukaemia.
Michor F; Hughes TP; Iwasa Y; Branford S; Shah NP; Sawyers CL; Nowak MA
Nature; 2005 Jun; 435(7046):1267-70. PubMed ID: 15988530
[TBL] [Abstract][Full Text] [Related]
16. Detection of BCR-ABL gene mutations in Philadelphia chromosome positive leukemia patients resistant to STI-571 cancer therapy.
Chien JH; Tang JL; Chen RL; Li CC; Lee CP
Leuk Res; 2008 Nov; 32(11):1724-34. PubMed ID: 18603297
[TBL] [Abstract][Full Text] [Related]
17. Abl tyrosine kinase inhibitors for overriding Bcr-Abl/T315I: from the second to third generation.
Tanaka R; Kimura S
Expert Rev Anticancer Ther; 2008 Sep; 8(9):1387-98. PubMed ID: 18759691
[TBL] [Abstract][Full Text] [Related]
18. Evidence of ABL-kinase domain mutations in highly purified primitive stem cell populations of patients with chronic myelogenous leukemia.
Sorel N; Bonnet ML; Guillier M; Guilhot F; Brizard A; Turhan AG
Biochem Biophys Res Commun; 2004 Oct; 323(3):728-30. PubMed ID: 15381060
[TBL] [Abstract][Full Text] [Related]
19. Differential contributions of STAT5A and STAT5B to stress protection and tyrosine kinase inhibitor resistance of chronic myeloid leukemia stem/progenitor cells.
Casetti L; Martin-Lannerée S; Najjar I; Plo I; Augé S; Roy L; Chomel JC; Lauret E; Turhan AG; Dusanter-Fourt I
Cancer Res; 2013 Apr; 73(7):2052-8. PubMed ID: 23400594
[TBL] [Abstract][Full Text] [Related]
20. BCR-ABL kinase is dead; long live the CML stem cell.
Perl A; Carroll M
J Clin Invest; 2011 Jan; 121(1):22-5. PubMed ID: 21157035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
